Alzheimers Attacking Ceo Company Drug Elan Kelly Martin Outlook Treat
Discussing Wyeth-Elan's drug to treat Alzheimer's diesease and an outlook on the company, with Kelly Martin, Elan CEO
CNBC | July 30, 2008
Tags:. .company. .attacking. .drug. .martin. .ceo